CDT Equity Inc. (CDT) vs Sunshine Biopharma, Inc. (SBFM)
A side-by-side comparison of CDT Equity Inc. and Sunshine Biopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CDT
CDT Equity Inc.
$0.86HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
SBFM
Sunshine Biopharma, Inc.
$0.37HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — CDT vs SBFM
growth of $100 · dividends reinvested · last 3yCDT -100.0% (-99.5%/yr)SBFM -99.9% (-91.6%/yr)SBFM compounded faster over this window
Log scale — wide-divergence pair
CDT SBFM
CDT vs SBFM: by the numbers
- •SBFM is the larger company ($880215 vs $665215 market cap).
- •CDT is profitable (6.30% net margin) while SBFM runs a net loss (-16.50%).
Metrics side by side
Valuation
| Metric | CDT | SBFM |
|---|---|---|
| P/S ratio | 0.00 | 0.02 |
| P/B ratio | 0.00 | 0.03 |
| EV / EBITDA | 4.13 | N/A |
Profitability
| Metric | CDT | SBFM |
|---|---|---|
| Gross margin | 0.00% | 29.80% |
| Operating margin | 0.00% | -14.71% |
| Net margin | 6.30% | -16.50% |
| ROE | 6.58% | -21.18% |
| ROIC | 4.47% | -18.56% |
Growth (annualized)
| Metric | CDT | SBFM |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 203.18% |
Frequently asked
- Is CDT or SBFM more profitable?
- CDT runs the higher net margin — CDT at 6.30% versus SBFM at -16.50%.
Go deeper
Dig into the metrics
CDT Equity ROESunshine Biopharma ROECDT Equity operating marginSunshine Biopharma operating marginCDT Equity revenue growthSunshine Biopharma revenue growthCDT Equity free cash flowSunshine Biopharma free cash flow
CDT Equity & Sunshine Biopharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.